Logo image of 1ROG.MI

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1ROG - CH0012032048 - Common Stock

342 EUR
+10 (+3.01%)
Last: 11/25/2025, 7:00:00 PM
Fundamental Rating

6

1ROG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. 1ROG scores excellent on profitability, but there are some minor concerns on its financial health. 1ROG has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year 1ROG was profitable.
1ROG had a positive operating cash flow in the past year.
Each year in the past 5 years 1ROG has been profitable.
In the past 5 years 1ROG always reported a positive cash flow from operatings.
1ROG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ROG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of 9.95%, 1ROG is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
With an excellent Return On Equity value of 32.88%, 1ROG belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.
1ROG has a Return On Invested Capital of 24.24%. This is amongst the best in the industry. 1ROG outperforms 92.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ROG is significantly above the industry average of 13.92%.
The 3 year average ROIC (23.72%) for 1ROG is below the current ROIC(24.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.95%
ROE 32.88%
ROIC 24.24%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
1ROG.MI Yearly ROA, ROE, ROIC1ROG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

With a Profit Margin value of 15.31%, 1ROG perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
1ROG's Profit Margin has declined in the last couple of years.
1ROG has a Operating Margin of 33.79%. This is amongst the best in the industry. 1ROG outperforms 85.45% of its industry peers.
1ROG's Operating Margin has been stable in the last couple of years.
1ROG has a Gross Margin of 73.92%. This is in the better half of the industry: 1ROG outperforms 69.09% of its industry peers.
1ROG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.79%
PM (TTM) 15.31%
GM 73.92%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
1ROG.MI Yearly Profit, Operating, Gross Margins1ROG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1ROG is creating value.
The number of shares outstanding for 1ROG has been reduced compared to 1 year ago.
Compared to 5 years ago, 1ROG has less shares outstanding
The debt/assets ratio for 1ROG is higher compared to a year ago.
1ROG.MI Yearly Shares Outstanding1ROG.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1ROG.MI Yearly Total Debt VS Total Assets1ROG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1ROG has an Altman-Z score of 4.46. This indicates that 1ROG is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.46, 1ROG is doing good in the industry, outperforming 65.45% of the companies in the same industry.
1ROG has a debt to FCF ratio of 2.50. This is a good value and a sign of high solvency as 1ROG would need 2.50 years to pay back of all of its debts.
1ROG has a Debt to FCF ratio of 2.50. This is in the better half of the industry: 1ROG outperforms 74.55% of its industry peers.
1ROG has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.06, 1ROG is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 2.5
Altman-Z 4.46
ROIC/WACC5.13
WACC4.73%
1ROG.MI Yearly LT Debt VS Equity VS FCF1ROG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

1ROG has a Current Ratio of 1.29. This is a normal value and indicates that 1ROG is financially healthy and should not expect problems in meeting its short term obligations.
1ROG has a Current ratio of 1.29. This is comparable to the rest of the industry: 1ROG outperforms 47.27% of its industry peers.
A Quick Ratio of 1.02 indicates that 1ROG should not have too much problems paying its short term obligations.
1ROG's Quick ratio of 1.02 is in line compared to the rest of the industry. 1ROG outperforms 58.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.02
1ROG.MI Yearly Current Assets VS Current Liabilites1ROG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

3

3. Growth

3.1 Past

1ROG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.19%.
The Earnings Per Share has been decreasing by -1.39% on average over the past years.
1ROG shows a small growth in Revenue. In the last year, the Revenue has grown by 4.77%.
Measured over the past years, 1ROG shows a decrease in Revenue. The Revenue has been decreasing by -0.32% on average per year.
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%

3.2 Future

Based on estimates for the next years, 1ROG will show a small growth in Earnings Per Share. The EPS will grow by 6.07% on average per year.
Based on estimates for the next years, 1ROG will show a small growth in Revenue. The Revenue will grow by 3.19% on average per year.
EPS Next Y5.57%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
EPS Next 5Y6.07%
Revenue Next Year2.13%
Revenue Next 2Y2.43%
Revenue Next 3Y2.75%
Revenue Next 5Y3.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ROG.MI Yearly Revenue VS Estimates1ROG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
1ROG.MI Yearly EPS VS Estimates1ROG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.21 indicates a correct valuation of 1ROG.
Based on the Price/Earnings ratio, 1ROG is valued a bit cheaper than 65.45% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1ROG to the average of the S&P500 Index (26.11), we can say 1ROG is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.32, which indicates a correct valuation of 1ROG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ROG indicates a somewhat cheap valuation: 1ROG is cheaper than 61.82% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.21. 1ROG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.21
Fwd PE 15.32
1ROG.MI Price Earnings VS Forward Price Earnings1ROG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

1ROG's Enterprise Value to EBITDA is on the same level as the industry average.
70.91% of the companies in the same industry are more expensive than 1ROG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.54
EV/EBITDA 12
1ROG.MI Per share data1ROG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of 1ROG may justify a higher PE ratio.
PEG (NY)2.91
PEG (5Y)N/A
EPS Next 2Y5.21%
EPS Next 3Y5.44%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.14%, 1ROG has a reasonable but not impressive dividend return.
1ROG's Dividend Yield is a higher than the industry average which is at 2.86.
1ROG's Dividend Yield is a higher than the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

The dividend of 1ROG has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1ROG pays out 85.87% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 1ROG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP85.87%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
1ROG.MI Yearly Income VS Free CF VS Dividend1ROG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1ROG.MI Dividend Payout.1ROG.MI Dividend Payout, showing the Payout Ratio.1ROG.MI Dividend Payout.PayoutRetained Earnings

ROCHE HOLDING AG-GENUSSCHEIN

BIT:1ROG (11/25/2025, 7:00:00 PM)

342

+10 (+3.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-23 2025-10-23
Earnings (Next)01-29 2026-01-29/amc
Inst Owners40.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap276.76B
Revenue(TTM)61.59B
Net Income(TTM)9.43B
Analysts70.37
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend10.84
Dividend Growth(5Y)2.37%
DP85.87%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 16.21
Fwd PE 15.32
P/S 4.19
P/FCF 19.54
P/OCF 13.38
P/B 9
P/tB 59.37
EV/EBITDA 12
EPS(TTM)21.1
EY6.17%
EPS(NY)22.32
Fwd EY6.53%
FCF(TTM)17.5
FCFY5.12%
OCF(TTM)25.55
OCFY7.47%
SpS81.64
BVpS38.01
TBVpS5.76
PEG (NY)2.91
PEG (5Y)N/A
Graham Number134.34
Profitability
Industry RankSector Rank
ROA 9.95%
ROE 32.88%
ROCE 30.98%
ROIC 24.24%
ROICexc 24.24%
ROICexgc 36.85%
OM 33.79%
PM (TTM) 15.31%
GM 73.92%
FCFM 21.43%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexgc growth 3Y2.54%
ROICexgc growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 2.5
Debt/EBITDA 1.27
Cap/Depr 195%
Cap/Sales 9.87%
Interest Coverage 17.17
Cash Conversion 80.58%
Profit Quality 140.01%
Current Ratio 1.29
Quick Ratio 1.02
Altman-Z 4.46
F-Score8
WACC4.73%
ROIC/WACC5.13
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
EPS Next Y5.57%
EPS Next 2Y5.21%
EPS Next 3Y5.44%
EPS Next 5Y6.07%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
Revenue Next Year2.13%
Revenue Next 2Y2.43%
Revenue Next 3Y2.75%
Revenue Next 5Y3.19%
EBIT growth 1Y10.03%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year25.3%
EBIT Next 3Y10.44%
EBIT Next 5Y8.74%
FCF growth 1Y12.91%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y19.07%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG.MI FAQ

Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-GENUSSCHEIN?

ChartMill assigns a fundamental rating of 6 / 10 to 1ROG.MI.


Can you provide the valuation status for ROCHE HOLDING AG-GENUSSCHEIN?

ChartMill assigns a valuation rating of 5 / 10 to ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ROCHE HOLDING AG-GENUSSCHEIN?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a profitability rating of 8 / 10.


Can you provide the expected EPS growth for 1ROG stock?

The Earnings per Share (EPS) of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is expected to grow by 5.57% in the next year.


Is the dividend of ROCHE HOLDING AG-GENUSSCHEIN sustainable?

The dividend rating of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is 4 / 10 and the dividend payout ratio is 85.87%.